載入...
Cumulative Cisplatin Dose Is Not Associated With Event-Free or Overall Survival in Children With Newly Diagnosed Average-Risk Medulloblastoma Treated With Cisplatin Based Adjuvant Chemotherapy: Report From the Children's Oncology Group
BACKGROUND: Survival rates for children with medulloblastoma have risen over the past decade, in part due to the addition of cisplatin-containing adjuvant chemotherapy. Total dose of cisplatin required for optimal treatment is unknown. The purpose of this study was to evaluate the survival outcomes...
Na minha lista:
| 發表在: | Pediatr Blood Cancer |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591537/ https://ncbi.nlm.nih.gov/pubmed/23956184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24670 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|